Loading...
XSHE
002788
Market cap597mUSD
Dec 05, Last price  
10.88CNY
1D
6.98%
1Q
27.70%
Jan 2017
-49.51%
IPO
0.83%
Name

Luyan Pharma Co Ltd

Chart & Performance

D1W1MN
XSHE:002788 chart
P/E
12.23
P/S
0.21
EPS
0.89
Div Yield, %
2.76%
Shrs. gr., 5y
2.05%
Rev. gr., 5y
6.40%
Revenues
20.47b
+3.15%
2,948,581,4964,687,352,4365,519,752,1556,299,801,6936,625,719,8756,982,884,9848,338,232,82311,500,890,95515,008,876,11815,531,278,46117,545,397,26719,462,501,27719,845,534,61420,470,766,084
Net income
346m
-4.92%
63,624,64090,513,942108,283,121109,327,452113,479,743115,523,095130,578,913180,324,647255,888,916266,627,871305,870,612345,155,498363,530,313345,644,716
CFO
577m
-55.89%
28,006,22200177,889,035219,30800126,770,170077,222,6450232,186,4451,309,117,195577,483,453
Dividend
Jul 04, 20240.3 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Luyan Pharma Co.,Ltd. engages in the research and development, production, and sale of human health products in China. It also operates pharmaceutical distribution and retail direct stores. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. Luyan Pharma Co.,Ltd. was founded in 1992 and is headquartered in Xiamen, China.
IPO date
Feb 18, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT